Tech Company Financing Transactions
Revagenix Funding Round
Revagenix, based in San Mateo, secured investment from Novo Holdings and Tenmile.
Transaction Overview
Company Name
Announced On
1/5/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Tenmile (Steve Burnell)
Proceeds Purpose
With the support of its investors, partners, and the strengthened capabilities of its leadership team, the Company is well-positioned to address the complex challenges in the development of new antibiotic therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1729 Dolan Ave
San Mateo, CA 94401-2126
USA
San Mateo, CA 94401-2126
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Revagenix exists to deliver urgently needed anti-infective medicines to patients around the world. To accomplish this, we design our therapeutic profiles and business strategy through a holistic understanding of the needs, opportunities, and challenges at each stage of the biopharmaceutical lifecycle, from research, to development, to commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Cirz
Chief Operating Officer
Andrew McCandlish
VP - Bus. Development
Daniel Cloutier
VP - Bus. Development
Mick Hurrey
Browse more venture capital transactions:
Prev: 1/5/2024: Bracket Labs venture capital transaction
Next: 1/5/2024: Reimagine Care venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs